Effect of intravenous Lidocaine in Endoscopy

Phase 3

Recruiting

• Conditions: Endoscopy,Sedation.; Failed moderate sedation during procedure; T88.52

• Registration Number: IRCT20220221054090N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 138

Inclusion Criteria

Candidate patients under 18 to 65 years of age who are in groups 1 and 2 according to the American Society of Anesthesiology (ASA Class)

Exclusion Criteria

Patients with severe heart or lung disease are not included in this study
Patients with Renal failure are not included in this study
Patients with Liver failure are not included in this study
Patients allergic to Propofol, Ketamine, or Lidocaine are not included in this study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total amount of Propofol consumed. Timepoint: From start to end of endoscopy. Method of measurement: Dose of drug.;Level of sedation. Timepoint: From start to end of endoscopy. Method of measurement: Ramsay Sedation Scale.;Amount of pain. Timepoint: From start to one hour after Endoscopy. Method of measurement: Visual Analogue Scale.;Amount of Nausea and Vomiting. Timepoint: From start to end of Endoscopy. Method of measurement: Visual Analogue Scale.;Time of recovery. Timepoint: From start to end of Endoscopy. Method of measurement: From end of endoscopy to full consciousness.;Hemodynamic instability. Timepoint: From start to end of Endoscopy. Method of measurement: Amount of Heart rate, mean arterial pressure and blood oxygen saturation changes.